Cumulative Radiation — From Repeated PET-CT Scans

There is no universally agreed lifetime limit for cancer patients. What exists instead is a clinical principle: each scan must be justified by the question it is answering. The ICRP and IAEA set frameworks for how dose and scan frequency should be weighed, and your oncologist applies those at every decision point. If scans feel routine rather than decision-driven, ask how long the current schedule is planned for and what the review point is.

The dose from a PET-CT comes from two sources — the CT component and the radiotracer — and the combined total varies depending on the type of scan, the scanner settings, and your body size. The ICRP and IAEA publish reference ranges for common protocols. Your nuclear medicine team can give you the estimated dose for your specific scan if you ask before you go in. That is a routine question and they are used to answering it.

The ICRP models a small theoretical increase in lifetime cancer risk from any radiation dose above background. For cancer patients, the risk from not scanning — a missed recurrence, a delayed response assessment — is generally much higher than that modelled radiation risk. ASCO and ESMO guidance supports scanning when it is clinically indicated on exactly this basis. The question your oncologist is balancing is whether the information the scan provides is worth the dose it adds.

Both doses are real and both are tracked, but they are very different in nature. Radiotherapy delivers a high, precisely targeted dose to a specific volume of tissue — that is how it works. Diagnostic scan doses are spread across the body at much lower levels. Your radiation oncologist keeps a treatment dose record. If you have had both, you can ask your nuclear medicine team for an estimate of your cumulative imaging dose — that is a reasonable request, and they are used to providing it.

Yes. Write down the date, the type of scan, and where it was done. This matters most if you move between hospitals or see more than one team — your imaging history helps avoid unnecessary repeat scans and gives any new team important context. Keep a copy of your reports if the centre gives them to you. Having your own record means you can give an accurate history wherever you are seen, without relying on records being transferred in time.

MRI uses magnetic fields rather than ionising radiation, so it carries no radiation dose. Whether it can replace a PET-CT depends entirely on what your oncologist needs to find out. PET-CT shows metabolic activity — whether tissue is biologically active — which MRI cannot replicate in the same way. For soft tissue detail or brain assessment, MRI is often more informative. Ask your oncologist what specific question the scan is answering, then ask whether MRI or another alternative could answer it equally well.

You are mildly radioactive for a few hours after the scan while the tracer clears from your body. Most nuclear medicine centres advise keeping some distance from young children and pregnant women during that period. Your team should give you written advice before you leave — follow that rather than general guidance, as instructions can vary slightly by tracer and dose. For most adults, normal family contact resumes by the same evening.

Three-monthly scanning is a recognised interval during and after active treatment for several cancers, and your oncologist has a specific clinical reason for that schedule. Whether it is right for you depends on your cancer type, your treatment phase, and what each scan has been showing. Ask at your next appointment: what question is this scan answering, and at what point is the interval expected to lengthen? Those are reasonable questions, and the answers will tell you how long the current schedule is planned for.